Label: information for the user
Aricept 10 mg film-coated tablets
Donepezil hydrochloride
Read this label carefully before you start taking this medicine, because it contains important information for you.
Aricept belongs to a group of medications called acetylcholinesterase inhibitors. Donepezil hydrochloride increases the levels in the brain of a substance related to memory (acetylcholine) by reducing the rate of breakdown of this substance.
It is used for the treatment of mild to moderately severe symptoms of Alzheimer's disease. Symptoms include increased memory loss, confusion, and changes in behavior.
Warnings and precautions
Consult your doctor before starting to takeAriceptif you have or have had:
You should avoid taking Aricept with other acetylcholinesterase inhibitors and other cholinergic agonists or antagonists.
Other medications and Aricept
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication and especially if you are taking any of the following medications:
In the event of surgery with general anesthesia, you should inform your doctor that you are taking Aricept as this may affect the amount of anesthetic needed.
Aricept may be used in patients with mild to moderate kidney or liver disease. Inform your doctor if you have any kidney or liver disease. Patients with severe liver disease should not take Aricept.
Aricept with food, drinks, and alcohol
This medication should be taken with a little water.
Aricept should not be taken with alcohol as alcohol may modify the effect of this medication.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, or intend to become pregnant,consult your doctor or pharmacist before using this medication.
You should not take Ariceptif you are breastfeeding your child.
Driving and operating machinery
Your condition may affect your ability to drive or operate machinery and you should not do so unless your doctor tells you it is safe to do so. Aricept may cause fatigue, dizziness, drowsiness, and muscle cramps, mainly at the start of treatment or when increasing the dose. If you experience these effects, you should not drive or operate machinery.
This medication contains lactose.If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
Ariceptis administered orally.
Aricept treatmentbegins with a 5 mg tablet, taken once a day with a little water, at night immediately before going to bed.After a month of treatment, your doctor may recommend an increase in the dose to 10 mg, once a day and at night.The maximum recommended dose is 10 mg per day.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend taking Aricept in the morning.
If you have mild or moderate liver disease (a disease that affects the liver) or kidney disease (a disease that affects the kidneys), you can take Aricept.Inform your doctor before starting treatment if you have liver or kidney problems.Patients with severe liver disease should not take Aricept.
Use in children
Aricept is not recommended for use in children.
If you take more Ariceptthan you should
If you have taken more Ariceptthan you should, consult your doctor, pharmacist, or call the Toxicological Information Service, phone: 91 562 04 20,indicating the medication and the amount used.
The symptoms of overdose may include nausea(feeling sick), vomiting(being sick), drooling, sweating, decreased heart rate, low blood pressure (dizziness or dizziness when standing up), breathing problems, loss of consciousness, and seizures.
If you forget to take Aricept
Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Aricept
Do not stop taking Aricept unless your doctor tells you to.If you stop taking Aricept, the benefits of treatment will gradually disappear.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, Aricept may cause side effects, although not everyone will experience them.
The following side effects have been reported by people taking Aricept.
Contact your doctor if you experience any of these side effects during treatment with Aricept.
Severe side effects:
You should inform your doctor immediately if you notice any of the following severe side effects, as you may need urgent medical treatment.
The estimated frequency of side effects is as follows:
Very common: may affect more than 1 in 10 patients
Common: may affect between 1 and 10 in 100 patients
Uncommon: may affect between 1 and 10 in 1,000 patients
Rare: may affect between 1 and 10 in 10,000 patients
Frequency not known (cannot be estimated from available data)
Reporting side effects
If you experience any type of sideseffects, consult your doctor or pharmacist, even if it is a side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use, Website:www.notificaRAM.es
Keep this medication out of the sight and reach of children.
Store below30°C.
Do not use Ariceptafter the expiration date that appears on the packaging.The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash.Deposit the containers and medicines you no longer need at the SIGRE collection pointof the pharmacy.In case of doubtask your pharmacist how to dispose of the containers and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Aricept 10 mg film-coated tablets
Appearance of the product and contents of the packaging
Aricept 10 mg film-coated tablets are available in a blister pack of 28 tablets, made of PVC with an aluminum foil backing.
Holder of the marketing authorization and responsible manufacturer
Holder of the marketing authorization:
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
Responsible manufacturer:
Fareva Amboise
Zone Industrielle
29 route des Industries
37530 Pocé-sur-Cisse
France
or
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
You can request more information about this medication by contacting the local representative of the holder of the marketing authorization:
Eisai Pharmaceutical, S.A.
Parque Empresarial Cristalia.
Calle Via de los Poblados 3, Edf. 7/8
4th floor
28033 Madrid
Phone: + (34) 91 455 94 55
Last review date of this leaflet: December 2022
“Detailed and updated information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/”
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.